Allogeneic virus-specific cytotoxic T-lymphocytes
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Allogeneic virus-specific cytotoxic T-lymphocytes, covering 2016-01-21 to 2016-04-26. Get the full timeline:
Most recent: Clinical Trial Update: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1, Phase 2]